Search
Tyrosyladenylate
go.drugbank.com/drugs/DB03325ExperimentalSynonyms: 5'-O-(L-Tyrosylsulfamoyl)adenosineBQ-788
go.drugbank.com/drugs/DB17984InvestigationalSynonyms: D-norleucine, n-(((2r,6s)-2,6-dimethyl-1-piperidinyl)carbonyl)-4-methyl-l-leucyl-1-(methoxycarbonyl)-d-tryptophyl-, sodium salt (1:1)Categories: Heterocyclic Compounds, 1-Ring, Endothelin B Receptor AntagonistsIndoximod
go.drugbank.com/drugs/DB12827InvestigationalIndoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others.
Synonyms: 1-methyl-D-tryptophan, D-1-methyltryptophanEzutromid
go.drugbank.com/drugs/DB12888InvestigationalEzutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.
Synonyms: 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo(d)oxazole, Benzoxazole, 5-(ethylsulfonyl)-2-(2-naphthalenyl)-Categories: Heterocyclic Compounds, 2-RingAvutometinib
go.drugbank.com/drugs/DB15254ApprovedInvestigational[L53203,L53198] The MAPK pathway is implicated in variety of cancers, playing a key role in tumor cell proliferation, differentiation and survival. … [A273948] Avutometinib was approved by the US FDA in May 2025 in a co-package alongside [defactinib] (called Avmapki Fakzynja) for the treatment of recurrent KRAS-mutated low-grade serous ovarian cancer
Synonyms: N-(3-fluoro-4-((4-methyl-2-oxo-7-((pyrimidin-2-yl)oxy)-2H-1-benzopyran-3-yl)methyl)pyridin-2-yl)-N'-methylsulfuric diamide, Sulfamide, N-(3-fluoro-4-((4-methyl-2-oxo-7-(2-pyrimidinyloxy)-2H-1-benzopyran-3-yl)methyl)-2-pyridinyl)-N'-methyl-Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 Substrates(S)-famoxadone
go.drugbank.com/drugs/DB07778ExperimentalSynonyms: (S)-5-Methyl-5-(4-phenoxy-phenyl)-3-phenylamino-oxazolidine-2,4-dione, (S)-famoxadoneBamethan
go.drugbank.com/drugs/DB13206ExperimentalSynonyms: N-Butylnorsynephrine, 1-(4-Hydroxyphenyl)-1-hydroxy-2-butylaminoethaneCategories: 2-Amino-1-Phenylethanol DerivativesN-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid
go.drugbank.com/drugs/DB04057ExperimentalSynonyms: N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid, β-DADF, MSA, multisubstrate adduct inhibitorTolebrutinib
go.drugbank.com/drugs/DB18715InvestigationalSynonyms: 2h-imidazo(4,5-c)pyridin-2-one, 4-amino-1,3-dihydro-1-((3r)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-, 4-amino-1,3-dihydro-1-((3r)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-2h-imidazo(4,5-c)pyridin-2-oneEsaprazole
go.drugbank.com/drugs/DB19808ExperimentalEsaprazole has a monoisotopic molecular weight of 225.18 Da. … Esaprazole is a small molecule drug. The usage of the INN stem '-prazole' in the name indicates that Esaprazole is a benzimidazole derivative antiulcer medication.
Synonyms: N-cyclohexyl-1-piperazineacetamide, N-(1-piperazinylacetyl)cyclohexylamineCategories: Heterocyclic Compounds, 1-Ring